News
24 Jul 2006
Barron joins DLA Piper's Corporate practice in Boston
Press Release
(BOSTON) - DLA Piper Rudnick Gray Cary US LLP announced that Michael Barron has joined the firm's Corporate and Securities practice group as a partner in the Boston office. He joins DLA Piper from Nixon Peabody LLP where he was one of the leaders of the firm's life sciences initiative.
Barron focuses his practice on representing early-stage biotechnology, medical device, healthcare and technology companies and investors in such companies. He counsels clients in corporate transactional and intellectual property matters. He has particular experience working with clients on early stage financings, licensing and trademark issues.
"Michael is widely respected in the legal and biotech communities and has extensive experience representing emerging growth companies with a particular emphasis on life sciences," said Elliot Surkin, managing partner of DLA Piper's Boston office. "His skills complement the firm's national life sciences practice, which stretches from Boston and Atlanta across to California and Seattle."
DLA Piper's Life Sciences practice includes more than 100 attorneys in the U.S. The firm has offices in 22 cities in the U.S., including all of the top life sciences markets in the country. The firm advises clients in all stages of growth-from start-ups to Fortune 500 companies. The products and services of the firm's life sciences clients include drug development, pharmaceuticals, diagnostics, bioinformatics, medical devices, bioengineering, telemedicine, and bioagriculture. DLA Piper also represents leading life sciences investors, including venture capital firms, entrepreneurs, and financial institutions, as well as some of the leading non-profit institutes in the U.S. and worldwide.
In 1995, Barron founded the Massachusetts Innovation & Technology Exchange (MITX), a trade organization that works as a catalyst for identifying, stimulating, fueling, and enabling new opportunities for today's technology professionals. MITX offers thought leadership, information on technology trends, networking opportunities, and professional training and development for its more than 2,500 members from financial services, healthcare, information technology, nanotechnology, and other forward-thinking companies. Barron serves as the General Counsel to MITX and is a member of MITX's Executive Committee.
A frequent author and lecturer, Barron was a speaker at the Biotechnology Industry Organization's premier annual event, BIO 2006. He is a member of the Boston Bar Association, the International Trademark Association, the Licensing Executive Society and the Massachusetts Biotechnology Council.
Barron received a J.D. from Boston University School of Law and a B.A. from Northwestern University.
About DLA Piper Rudnick Gray CaryDLA Piper Rudnick Gray Cary has 3,100 lawyers and 59 offices in 22 countries throughout the U.S., U.K., Continental Europe, Middle East and Asia. It has leading practices in commercial, corporate and finance, human resources, litigation, real estate, regulatory and legislative, and technology, media and communications.
###
CONTACTS:
Elliot Surkin, Managing Partner, Boston office, DLA Piper, 617.406.6030
Michael K. Barron, Partner, Boston office, DLA Piper, 617.406.6006
Frank Feeney, Partner, Boston office, DLA Piper, 617.406.6063
Laura Miller, Media Relations, GreenTarget, 312.252.4104
This information is intended as a general overview and discussion of the subjects dealt with. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. DLA Piper is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.
Copyright © 2012 DLA Piper. All rights reserved.